<code id='0280CADA35'></code><style id='0280CADA35'></style>
    • <acronym id='0280CADA35'></acronym>
      <center id='0280CADA35'><center id='0280CADA35'><tfoot id='0280CADA35'></tfoot></center><abbr id='0280CADA35'><dir id='0280CADA35'><tfoot id='0280CADA35'></tfoot><noframes id='0280CADA35'>

    • <optgroup id='0280CADA35'><strike id='0280CADA35'><sup id='0280CADA35'></sup></strike><code id='0280CADA35'></code></optgroup>
        1. <b id='0280CADA35'><label id='0280CADA35'><select id='0280CADA35'><dt id='0280CADA35'><span id='0280CADA35'></span></dt></select></label></b><u id='0280CADA35'></u>
          <i id='0280CADA35'><strike id='0280CADA35'><tt id='0280CADA35'><pre id='0280CADA35'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:2
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi
          FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

          AdobeExpertadviserstotheFoodandDrugAdministrationonFridayvotedunanimouslyinfavorof expandingtheappro

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Readout Newsletter: Beam, Prozac, "TechBio" and more

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo